NCT00163098 - A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD | Biotech Hunter

Enrollment

136

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

December 31, 2005

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

UK-369,003

Trial Locations (28)

1272

Pfizer Investigational Site, Buenos Aires

1427

Pfizer Investigational Site, Buenos Aires

2000

Pfizer Investigational Site, Rosario

2010

Pfizer Investigational Site, Darlinghurst

2050

Pfizer Investigational Site, Camperdown

3004

Pfizer Investigational Site, Melbourne

4000

Pfizer Investigational Site, San Miguel de Tucumán

4032

Pfizer Investigational Site, Chermside

5000

Pfizer Investigational Site, Adelaide

6000

Pfizer Investigational Site, Perth

35392

Pfizer Investigational Site, Giessen

35753

Pfizer Investigational Site, Greifestein

400016

Pfizer Investigational Site, Mumbai

600116

Pfizer Investigational Site, Chennai

632002

Pfizer Investigational Site, Vellore

682026

Pfizer Investigational Site, Kochi

CP 5016

Pfizer Investigational Site, Córdoba

Unknown

Pfizer Investigational Site, San Miguel de Tucumán

Pfizer Investigational Site

C1425DQi

Pfizer Investigational Site, Ciudad de Beurnos Aires

(C1425DTG)

Pfizer Investigational Site, Ciudad de Buenos Aires,

C1115AAB

Pfizer Investigational Site, Ciudad de Buenos Aires

C1416DRV

Pfizer Investigational Site, Ciudad de Buenos Aires

(1605)

Pfizer Investigational Site, Provincia de Buenos Aires

411 019

Pfizer Investigational Site, Pune

CB3 8RE

Pfizer Investigational Site, Papworth Everard

G11 6NT

Pfizer Investigational Site, Glasgow

NE7 7DN

Pfizer Investigational Site, Newcastle upon Tyne